January 05, 2022

The Future of Due Diligence in Healthcare M&A

COVID-19 placed healthcare squarely in the center of everyone’s mind. From fledgling startups to large corporates, the healthcare industry is modernizing itself at lightning speed.

To make that happen, deal activity within healthcare has exploded at dizzying rates. R&D breakthroughs, point-of-care disruption, and strategic plays into digital health make the healthcare sector one rich with opportunity and risk. To manage that risk, staying on top of due diligence best practices is critical. In this whitepaper, we explore:

  • Current healthcare M&A due diligence benchmarks 
  • Trends reshaping the face of healthcare due diligence
  • An updated healthcare due diligence checkup list

Download the whitepaper and learn more. 

Ready to Get Started?

You may also like:

Datasite Forecaster November Global Outlook

Check out this month's Forecaster, where we provide a quick update on where the M&A market is heading, based on aggregated and anonymized data room activity.

Deal Drivers: APAC Q3 2022

Current macroeconomics presents a challenging environment for dealmakers to navigate. The data from Q3 2022 puts M&A in APAC at a critical juncture as dealmaking reaches pre-Covid levels. Will the markets normalize from here on or will they go into a downward spiral? Learn more from our latest Deal Drivers report.

Deal Drivers: Americas Q3 2022

A look back on M&A deal activity in the US, Canada and Latin America in Q3 2022. What regions and sectors look ripe for opportunity going forward? Find out in our latest report.

New York City Landscape